Sunshine Biopharma Inc.
SBFMW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001402328
No open-market purchases or sales by Sunshine Biopharma Inc. insiders were filed in the last 90 days; 3 institutions reported holding it in 13F filings for Q2 2026, worth $2.57K in total; no superinvestor holds it.
Other share classesSBFM
Q4 2022 vs. Q3 2022
How the institutions holding Sunshine Biopharma Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 4 | 1 | 3 | 0 |
| Shares | 69.9K | 15.0K | 39.7K | −15.2K (−27.7%) |
| Value | $27.0K | $7.00K | $12.3K | −$7.68K (−38.4%) |
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (0)
Institutions that held Sunshine Biopharma Inc. at the end of Q4 2022 but not at the end of Q3 2022.
None.
Sold out (0)
Institutions that held Sunshine Biopharma Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
None.
Not filed for Q4 2022 yet (1)
Institutions that held Sunshine Biopharma Inc. at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Empery Asset Management, LP | 14,986 | $7.00K |